Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)

Blood (2023) 142 (Supplement 1): 737.

https://doi.org/10.1182/blood-2023-179169

Published: 2023

Journal Articles

Immune-Related Gene Expression Signatures Identify a Patient's Subset Achieving Durable Complete Response to Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma

Paulina Nierychlewska, Maria Rosaria Sapienza, Alessandro Davini, Eugenia Montanari, Anna Vanazzi, Simonetta Viviani, Valentina Tabanelli, Roberto Massimo Lemoli, Corrado Tarella, Stefano Pileri, Enrico Derenzini

Blood (2023) 142 (Supplement 1): 1644.

https://doi.org/10.1182/blood-2023-186819

Published: 2023

Journal Articles

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Blood (2022) 140 (11): 1278–1290.

https://doi.org/10.1182/blood.2021015019

Published: 2022

Includes: Supplemental data

Journal Articles

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Blood (2019) 134 (24): 2159–2170.

https://doi.org/10.1182/blood.2019000779

Published: 2019

Includes: Supplemental data

Journal Articles

Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making

Blood (2019) 134 (Supplement_1): 661.

https://doi.org/10.1182/blood-2019-126767

Published: 2019

Journal Articles

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Safaa M. Ramadan, PhD MD, Alessandro Cignetti, MD PhD, Simona Sammassimo, MD, Enrico Derenzini, MD PhD, Giusy Ceparano, MD, Tommaso Radice, MD, Federica Gigli, MD, Stefano Fiori, MD, Valentina Tabanelli, MD, Martina Milani, Emanuela Omodeo Sale', Sara Gandini, PhD, Daniela Gottardi, MD, Giuseppe Saglio, MD, Stefano Pileri, MD, Corrado Tarella, MD

Blood (2019) 134 (Supplement_1): 1631.

https://doi.org/10.1182/blood-2019-128794

Published: 2019

Journal Articles

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Blood (2019) 133 (15): 1664–1676.

https://doi.org/10.1182/blood-2018-09-872549

Published: 2019

Includes: Supplemental data

Journal Articles

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Blood (2015) 125 (16): 2530–2543.

https://doi.org/10.1182/blood-2014-12-619783

Published: 2015

Includes: Supplemental data

Journal Articles

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Eva Hoster, PhD, Andreas Rosenwald, MD, Francoise Berger, MD PhD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Michael Unterhalt, MD, Johanna C. Kluin-Nelemans, Olivier Hermine, MD PhD, Wolfgang Hiddemann, MD PhD, Martin H. Dreyling, Wolfram Klapper, MD

Blood (2014) 124 (21): 2977.

https://doi.org/10.1182/blood.V124.21.2977.2977

Published: 2014

Journal Articles

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Blood (2013) 122 (15): 2683–2693.

https://doi.org/10.1182/blood-2013-04-497933

Published: 2013

Includes: Supplemental data

Journal Articles

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Luca Agnelli, Elisabetta Mereu, Elisa Pellegrino, Tania Limongi, Ivo Kwee, Elisa Bergaggio, Maurilio Ponzoni, Alberto Zamò, Javeed Iqbal, Pier Paolo Piccaluga, Antonino Neri, Wing C. Chan, Stefano Pileri, Francesco Bertoni, Giorgio Inghirami, Roberto Piva

Blood (2012) 120 (6): 1274–1281.

https://doi.org/10.1182/blood-2012-01-405555

Published: 2012

Includes: Supplemental data

Journal Articles

BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL)

Blood (2011) 118 (21): 2634.

https://doi.org/10.1182/blood.V118.21.2634.2634

Published: 2011

Journal Articles

Combination of Epigenetic Agents Synergistically Reverse the Malignant Phenotype in Models of T-Cell Lymphoma

Enrica Marchi, MD, Ph.D., Matko Kalac, MD, Ph.D., Danielle C Bongero, Christine M McIntosh, Laura K Fogli, Luigi Scotto, Ph.D., Maura Rossi, Ph.D., Pier Luigi Zinzani, MD, PhD, Stefano Pileri, MD, Pier Paolo Piccaluga, Sr., MD, PhD, Owen A. O'Connor, MD, PhD

Blood (2011) 118 (21): 2727.

https://doi.org/10.1182/blood.V118.21.2727.2727

Published: 2011

Journal Articles

The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma

Enrico Derenzini, MD, Ilaria Iacobucci, PhD, Elisa Brighenti, PhD, Federica Cattina, MD, Richard Eric Davis, MD, Stefano Pileri, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Pier Luigi Zinzani, MD

Blood (2011) 118 (21): 2732.

https://doi.org/10.1182/blood.V118.21.2732.2732

Published: 2011

Journal Articles

Clonality and Phenotype in Spleens From Patients with Primary Immune Thrombocytopenia,

Elena Sabattini, Sr., MD, Pier Paolo Piccaluga, Sr., MD, PhD, Claudia Mannu, BS, Anna Candoni, Anna Gazzola, Carlo Sagramoso, Eleonora Toffoletti, Nicola Vianelli, MD, Nicola Polverelli, MD, Stefano Pileri, MD, Carla Di Loreto, Sr., MD. Prof, Stefano Pizzolitto, Sr., MD, Francesco Zaja, MD

Blood (2011) 118 (21): 3291.

https://doi.org/10.1182/blood.V118.21.3291.3291

Published: 2011

Journal Articles

Potential Pathogenetic Role of Achromobacter (Alcaligenes) Xylosoxidans in Primary Extranodal Marginal Zone Lymphoma of the Lung (BALT-Lymphoma): Update of the Results of a Retrospective Analysis on Behalf of IELSG

Blood (2011) 118 (21): 880.

https://doi.org/10.1182/blood.V118.21.880.880

Published: 2011

Journal Articles

Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas

Pier Paolo Piccaluga, Sr., MD, PhD, Maria Antonella Laginestra, BS, Maura Rossi, PhD, Antonio De Leo, MD, Davide Gibellini, MD, Anna Gazzola, maria Rosaria Sapienza, PhD, Claudio Agostinelli, M.D., Ph.D., Stefano Pileri, MD

Blood (2011) 118 (21): 773.

https://doi.org/10.1182/blood.V118.21.773.773

Published: 2011

Journal Articles

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

Blood (2011) 118 (1): 148–155.

https://doi.org/10.1182/blood-2011-02-335216

Published: 2011

Includes: Supplemental data

Journal Articles

The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway

Paola Martinelli, Paola Bonetti, Cristina Sironi, Giancarlo Pruneri, Caterina Fumagalli, Paola Rafaniello Raviele, Sara Volorio, Stefano Pileri, Roberto Chiarle, Fiona Kate Elizabeth McDuff, Betsabeh Khoramian Tusi, Suzanne D. Turner, Giorgio Inghirami, Pier Giuseppe Pelicci, Emanuela Colombo

Blood (2011) 117 (24): 6617–6626.

https://doi.org/10.1182/blood-2010-08-301135

Published: 2011

Includes: Supplemental data

Journal Articles

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Elias Campo, Steven H. Swerdlow, Nancy L. Harris, Stefano Pileri, Harald Stein, Elaine S. Jaffe

Blood (2011) 117 (19): 5019–5032.

https://doi.org/10.1182/blood-2011-01-293050

Published: 2011

NARROW

Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)

Immune-Related Gene Expression Signatures Identify a Patient's Subset Achieving Durable Complete Response to Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL)

Combination of Epigenetic Agents Synergistically Reverse the Malignant Phenotype in Models of T-Cell Lymphoma

The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma

Clonality and Phenotype in Spleens From Patients with Primary Immune Thrombocytopenia,

Potential Pathogenetic Role of Achromobacter (Alcaligenes) Xylosoxidans in Primary Extranodal Marginal Zone Lymphoma of the Lung (BALT-Lymphoma): Update of the Results of a Retrospective Analysis on Behalf of IELSG

Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only